|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Raja FA, Counsell N, Colombo N, Pfisterer
J, du Bois A, Parmar MK, Vergote IB, Gonzalez-Martin A, Alberts DS,
Plante M, et al: Platinum versus platinum-combination chemotherapy
in platinum-sensitive recurrent ovarian cancer: A meta-analysis
using individual patient data. Ann Oncol. 24:3028–3034. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bookman MA: First-line chemotherapy in
epithelial ovarian cancer. Clin Obstet Gynecol. 55:96–113. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muggia F: Platinum compounds 30 years
after the introduction of cisplatin: Implications for the treatment
of ovarian cancer. Gynecol Oncol. 112:275–281. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maloyan A, Sayegh J, Osinska H, Chua BH
and Robbins J: Manipulation of death pathways in desmin-related
cardiomyopathy. Circ Res. 106:1524–1532. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ali AY, Farrand L, Kim JY, Byun S, Suh JY,
Lee HJ and Tsang BK: Molecular determinants of ovarian cancer
chemoresistance: New insights into an old conundrum. Ann NY Acad
Sci. 1271:58–67. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galluzzi L, Senovilla L, Vitale I, Michels
J, Martins I, Kepp O, Castedo M and Kroemer G: Molecular mechanisms
of cisplatin resistance. Oncogene. 31:1869–1883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang J and Wu GS: Role of autophagy in
cisplatin resistance in ovarian cancer cells. J Biol Chem.
289:17163–17173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu L, Gu C, Zhong D, Shi L, Kong Y, Zhou Z
and Liu S: Induction of autophagy counteracts the anticancer effect
of cisplatin in human esophageal cancer cells with acquired drug
resistance. Cancer Lett. 355:34–45. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bao L, Jaramillo MC, Zhang Z, Zheng Y, Yao
M, Zhang DD and Yi X: Induction of autophagy contributes to
cisplatin resistance in human ovarian cancer cells. Mol Med Rep.
11:91–98. 2015.PubMed/NCBI
|
|
11
|
Zhang Y, Cheng Y, Ren X, Zhang L, Yap KL,
Wu H, Patel R, Liu D, Qin ZH, Shih IM, et al: NAC1 modulates
sensitivity of ovarian cancer cells to cisplatin by altering the
HMGB1-mediated autophagic response. Oncogene. 31:1055–1064. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen N and Karantza V: Autophagy as a
therapeutic target in cancer. Cancer Biol Ther. 11:157–168. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng W, Huang S, Wu H and Zhang M:
Molecular basis of Bcl-xL's target recognition versatility revealed
by the structure of Bcl-xL in complex with the BH3 domain of
Beclin-1. J Mol Biol. 372:223–235. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pattingre S, Tassa A, Qu X, Garuti R,
Liang XH, Mizushima N, Packer M, Schneider MD and Levine B: Bcl-2
antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell.
122:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takayama S, Xie Z and Reed JC: An
evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone
regulators. J Biol Chem. 274:781–786. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fuchs M, Poirier DJ, Seguin SJ, Lambert H,
Carra S, Charette SJ and Landry J: Identification of the key
structural motifs involved in HspB8/HspB6-Bag3 interaction. Biochem
J. 425:245–255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Knezevic T, Myers VD, Gordon J, Tilley DG,
Sharp TE III, Wang J, Khalili K, Cheung JY and Feldman AM: BAG3: A
new player in the heart failure paradigm. Heart Fail Rev.
20:423–434. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carra S, Seguin SJ and Landry J: HspB8 and
Bag3: A new chaperone complex targeting misfolded proteins to
macroautophagy. Autophagy. 4:237–239. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Colvin T, Rauch JN, Acosta-Alvear D,
Kampmann M, Dunyak B, Hann B, Aftab BT, Murnane M, Cho M, et al:
Validation of the Hsp70-Bag3 protein-protein interaction as a
potential therapeutic target in cancer. Mol Cancer Ther.
14:642–648. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu F, Liu D, Yang Y and Zhao S: Effect of
autophagy inhibition on chemotherapy-induced apoptosis in A549 lung
cancer cells. Oncol Lett. 5:1261–1265. 2013.PubMed/NCBI
|
|
21
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu YL, Jahangiri A, Delay M and Aghi MK:
Tumor cell autophagy as an adaptive response mediating resistance
to treatments such as antiangiogenic therapy. Cancer Res.
72:4294–4299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saldivar JS, Wu X, Follen M and Gershenson
D: Nucleotide excision repair pathway review I: Implications in
ovarian cancer and platinum sensitivity. Gynecol Oncol. 107 Suppl
1:S56–S71. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Foo J and Michor F: Evolution of acquired
resistance to anti-cancer therapy. J Theor Biol. 355:10–20. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dikic I, Johansen T and Kirkin V:
Selective autophagy in cancer development and therapy. Cancer Res.
70:3431–3434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
O'Donovan TR, O'Sullivan GC and McKenna
SL: Induction of autophagy by drug-resistant esophageal cancer
cells promotes their survival and recovery following treatment with
chemotherapeutics. Autophagy. 7:509–524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fukuda T, Oda K, Wada-Hiraike O, Sone K,
Inaba K, Ikeda Y, Miyasaka A, Kashiyama T, Tanikawa M, Arimoto T,
et al: The anti-malarial chloroquine suppresses proliferation and
overcomes cisplatin resistance of endometrial cancer cells via
autophagy inhibition. Gynecol Oncol. 137:538–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Felzen V, Hiebel C, Koziollek-Drechsler I,
Reißig S, Wolfrum U, Kögel D, Brandts C, Behl C and Morawe T:
Estrogen receptor α regulates non-canonical autophagy that provides
stress resistance to neuroblastoma and breast cancer cells and
involves BAG3 function. Cell Death Dis. 6:e18122015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sherman MY and Gabai VL: Hsp70 in cancer:
Back to the future. Oncogene. 34:4153–4161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosati A, Graziano V, De Laurenzi V,
Pascale M and Turco MC: BAG3: A multifaceted protein that regulates
major cell pathways. Cell Death Dis. 2:e1412011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Iwasaki M, Homma S, Hishiya A, Dolezal SJ,
Reed JC and Takayama S: BAG3 regulates motility and adhesion of
epithelial cancer cells. Cancer Res. 67:10252–10259. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rosati A, Ammirante M, Gentilella A,
Basile A, Festa M, Pascale M, Marzullo L, Belisario MA, Tosco A,
Franceschelli S, et al: Apoptosis inhibition in cancer cells: A
novel molecular pathway that involves BAG3 protein. Int J Biochem
Cell Biol. 39:1337–1342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Behl C: Breaking BAG: The co-chaperone
BAG3 in health and disease. Trends Pharmacol Sci. 37:672–688. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nymoen DA, Falkenthal TE Hetland, Holth A,
Ow GS, Ivshina AV, Tropé CG, Kuznetsov VA, Staff AC and Davidson B:
Expression and clinical role of chemoresponse-associated genes in
ovarian serous carcinoma. Gynecol Oncol. 139:30–39. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suzuki M, Iwasaki M, Sugio A, Hishiya A,
Tanaka R, Endo T, Takayama S and Saito T: BAG3 (BCL2-associated
athanogene 3) interacts with MMP-2 to positively regulate invasion
by ovarian carcinoma cells. Cancer Lett. 303:65–71. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Habata S, Iwasaki M, Sugio A, Suzuki M,
Tamate M, Satohisa S, Tanaka R and Saito T: BAG3 increases the
invasiveness of uterine corpus carcinoma cells by suppressing
miR-29b and enhancing MMP2 expression. Oncol Rep. 33:2613–2621.
2015.PubMed/NCBI
|
|
37
|
Habata S, Iwasaki M, Sugio A, Suzuki M,
Tamate M, Satohisa S, Tanaka R and Saito T: BAG3-mediated Mcl-1
stabilization contributes to drug resistance via interaction with
USP9X in ovarian cancer. Int J Oncol. 49:402–410. 2016.PubMed/NCBI
|
|
38
|
Zhang J, He Z, Xiao W, Na Q, Wu T, Su K
and Cui X: Overexpression of BAG3 attenuates hypoxia-induced
cardiomyocyte apoptosis by inducing autophagy. Cell Physiol
Biochem. 39:491–500. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jacobs AT and Marnett LJ: HSF1-mediated
BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated
colon cancer cells via stabilization of anti-apoptotic Bcl-2
proteins. J Biol Chem. 284:9176–9183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Doong H, Rizzo K, Fang S, Kulpa V,
Weissman AM and Kohn EC: CAIR-1/BAG-3 abrogates heat shock
protein-70 chaperone complex-mediated protein degradation:
Accumulation of poly-ubiquitinated Hsp90 client proteins. J Biol
Chem. 278:28490–28500. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Beere HM: Death versus survival:
Functional interaction between the apoptotic and stress-inducible
heat shock protein pathways. J Clin Invest. 115:2633–2639. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Carra S, Seguin SJ, Lambert H and Landry
J: HspB8 chaperone activity toward poly(Q)-containing proteins
depends on its association with Bag3, a stimulator of
macroautophagy. J Biol Chem. 283:1437–1444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gamerdinger M, Hajieva P, Kaya AM, Wolfrum
U, Hartl FU and Behl C: Protein quality control during aging
involves recruitment of the macroautophagy pathway by BAG3. EMBO J.
28:889–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sariyer IK, Merabova N, Patel PK, Knezevic
T, Rosati A, Turco MC and Khalili K: Bag3-induced autophagy is
associated with degradation of JCV oncoprotein, T-Ag. PLoS One.
7:e450002012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qiao S, Tao S, de la Vega M Rojo, Park SL,
Vonderfecht AA, Jacobs SL, Zhang DD and Wondrak GT: The
antimalarial amodiaquine causes autophagic-lysosomal and
proliferative blockade sensitizing human melanoma cells to
starvation- and chemotherapy-induced cell death. Autophagy.
9:2087–2102. 2013. View Article : Google Scholar : PubMed/NCBI
|
